Michael A. Riegelman

Array ( [id] => 20567152 [patent_doc_number] => 20260061070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-03-05 [patent_title] => COMPOSITIONS AND METHODS FOR TUNABLE MAGNETIC NANOPARTICLES [patent_app_type] => utility [patent_app_number] => 19/379726 [patent_app_country] => US [patent_app_date] => 2025-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12913 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19379726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20599070 [patent_doc_number] => 20260077073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-03-19 [patent_title] => GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-TARGETED COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 19/334526 [patent_app_country] => US [patent_app_date] => 2025-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41345 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19334526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20320213 [patent_doc_number] => 20250332301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-30 [patent_title] => STABLE, CONCENTRATED RADIOPHARMACEUTICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 19/234864 [patent_app_country] => US [patent_app_date] => 2025-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7701 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19234864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19996829 [patent_doc_number] => 20250135051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-01 [patent_title] => YTTRIUM [90Y] MICROSPHERE AND PREPARATION METHOD THEREFOR AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/567299 [patent_app_country] => US [patent_app_date] => 2023-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1274 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18567299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19111347 [patent_doc_number] => 20240123097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => Dual-Mode Pharmaceutical Composition for Peptide-Specific Targeted Positron Emission Tomography and Boron Neutron Capture Therapy and the Use Thereof [patent_app_type] => utility [patent_app_number] => 18/473324 [patent_app_country] => US [patent_app_date] => 2023-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1771 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18473324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19031948 [patent_doc_number] => 20240081763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => MEDICAL DEVICE OPERATION METHOD AND DRUG TREATMENT SUPPORT SYSTEM [patent_app_type] => utility [patent_app_number] => 18/463384 [patent_app_country] => US [patent_app_date] => 2023-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12782 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18463384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18806850 [patent_doc_number] => 20230381183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => USE OF FOLIC ACID AND FOLATE MODIFICATION IN INDUCING B-CELL IMMUNE TOLERANCE AND TARGETING mIgM-POSITIVELY-EXPRESSED B-CELL LYMPHOMA [patent_app_type] => utility [patent_app_number] => 18/304987 [patent_app_country] => US [patent_app_date] => 2023-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15562 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18304987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18808522 [patent_doc_number] => 20230382855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => REACTIONS OF RADIOACTIVE COMPOUNDS FACILITATED BY A SOLID PHASE [patent_app_type] => utility [patent_app_number] => 18/182076 [patent_app_country] => US [patent_app_date] => 2023-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33373 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18182076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18647951 [patent_doc_number] => 20230293734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => FLUORINE-CONTAINING COMPOUND AND CONTRAST AGENT [patent_app_type] => utility [patent_app_number] => 18/119456 [patent_app_country] => US [patent_app_date] => 2023-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13906 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18119456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18626792 [patent_doc_number] => 20230285600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => TUMOR TARGETED DIAGNOSTIC IMAGING AGENT FOR DIAGNOSTIC BIOPSY, OR INTRAOPERATIVE TUMOR IDENTIFICATION OR MARGIN ASSESSMENT USING NEAR-INFRARED FLUORESCENCE (NIRF) IMAGING [patent_app_type] => utility [patent_app_number] => 18/104436 [patent_app_country] => US [patent_app_date] => 2023-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7199 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18104436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18391329 [patent_doc_number] => 20230159547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => COMPOUND AND LABELED BIOLOGICAL SUBSTANCE USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/069982 [patent_app_country] => US [patent_app_date] => 2022-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 288 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18069982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18434496 [patent_doc_number] => 20230181790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => RADIOACTIVE SHEAR THINNING BIOMATERIAL COMPOSITION AND METHODS FOR USE [patent_app_type] => utility [patent_app_number] => 18/080899 [patent_app_country] => US [patent_app_date] => 2022-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5059 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18080899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19940174 [patent_doc_number] => 12312295 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-05-27 [patent_title] => Chemical compound that binds to nerves while permitting detection via computed tomography or x-ray [patent_app_type] => utility [patent_app_number] => 17/989489 [patent_app_country] => US [patent_app_date] => 2022-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 8 [patent_no_of_words] => 0 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17989489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18257496 [patent_doc_number] => 20230084536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => PHARMACEUTICAL COMPOSITIONS FOR IMAGING, DIAGNOSIS AND TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 17/942911 [patent_app_country] => US [patent_app_date] => 2022-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8939 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17942911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18254947 [patent_doc_number] => 20230081986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => METHOD AND REAGENTS TO IMPROVE NONANIMAL OCULAR TOXICITY TESTS [patent_app_type] => utility [patent_app_number] => 17/889026 [patent_app_country] => US [patent_app_date] => 2022-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10848 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17889026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18178786 [patent_doc_number] => 20230039515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => NANODROPLETS WITH IMPROVED PROPERTIES [patent_app_type] => utility [patent_app_number] => 17/882797 [patent_app_country] => US [patent_app_date] => 2022-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9271 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17882797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18842752 [patent_doc_number] => 20230405156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => METHODS OF DIAGNOSING AND PROGNOSING CANCERS OF THE HEAD AND NECK [patent_app_type] => utility [patent_app_number] => 17/816317 [patent_app_country] => US [patent_app_date] => 2022-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22377 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18254066 [patent_doc_number] => 20230081105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => EXOSOME-DELIVERED TARGETING TREATMENT FOR BLOOD VESSELS [patent_app_type] => utility [patent_app_number] => 17/865513 [patent_app_country] => US [patent_app_date] => 2022-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5723 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17865513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20562902 [patent_doc_number] => 12565503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-03 [patent_title] => Cyclic Gd (III) complex and preparation method and use thereof [patent_app_type] => utility [patent_app_number] => 17/997450 [patent_app_country] => US [patent_app_date] => 2022-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 12487 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18281821 [patent_doc_number] => 20230097293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => LMP1 TARGETING LANTHANIDE COMPLEXES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/807900 [patent_app_country] => US [patent_app_date] => 2022-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11740 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17807900 [rel_patent_id] =>[rel_patent_doc_number] =>)